What was very interesting about the Moiety comment was that Paul was saying Bene are the Only producer of IPPS that can produce a consistent level of it in the product due to there processes. Nobody else has been able to replicate it which is why they are the only approved FDA supplier. Also he seemed to infer that an incorrect balance of Moiety was detrimental (Did the guys listening think that as well?).
Back to the Pool
Ann: Paradigm to present at Virtual Conference, Friday 27th March, page-30
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $71.73M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 20.0¢ | $152.8K | 744.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 78174 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 84426 | 5 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |